6 studies were found.

1.		Completed	A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers Condition: HIV Infections
2.		Completed	A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy Conditions: Lymphatic Disease; HIV Infections
3.		Completed	A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC) Condition: HIV Infections
4.		Completed	The Safety and Effectiveness of Isoprinosine in Patients with Weakened Immune Systems and Lymph Node Disease Conditions: Lymphatic Disease; HIV Infections
5.		Completed	A Study of Isoprinosine in Patients with Lymph Node Disease Conditions: Lymphatic Disease; HIV Infections
6.		Completed	A Study of Isoprinosine in Patients with Severe AIDS Condition: HIV Infections